Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-12 4:31 pm Sale | 2020-12-31 | 13G | Verastem, Inc. VSTM | Ikarian Capital LLC | 187,883 1.300% | -233,107 (-55.37%) | Filing History |
| 2021-02-12 4:31 pm Purchase | 2020-12-31 | 13G | Protara Therapeutics, Inc. TARA | Ikarian Capital LLC | 649,542 5.800% | 649,542 (New Position) | Filing History |
| 2021-01-11 5:25 pm Purchase | 2020-08-03 | 13G | Milestone Pharmaceuticals Inc. MIST | Ikarian Capital LLC | 1,836,545 6.200% | 1,836,545 (New Position) | Filing History |
| 2021-01-11 5:24 pm Purchase | 2020-11-24 | 13G | LifeSci Acquisition II Corp. LSAQ | Ikarian Capital LLC | 512,450 6.400% | 512,450 (New Position) | Filing History |
| 2021-01-08 9:59 pm Purchase | 2020-12-23 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Ikarian Capital LLC | 26,667 8.200% | 26,667 (New Position) | Filing History |
| 2021-01-08 9:59 pm Purchase | 2020-09-18 | 13G | Aerpio Pharmaceuticals, Inc. ARPO | Ikarian Capital LLC | 31,719 1.000% | 31,719 (New Position) | Filing History |
| 2021-01-08 9:57 pm Purchase | 2020-12-24 | 13G | Bellicum Pharmaceuticals, Inc. BLCM | Ikarian Capital LLC | 500,000 9.900% | 500,000 (New Position) | Filing History |
| 2020-12-30 5:26 pm Purchase | 2020-12-29 | 13G | X4 Pharmaceuticals, Inc. XFOR | Ikarian Capital LLC | 826,424 5.100% | 826,424 (New Position) | Filing History |
| 2020-12-30 5:26 pm Purchase | 2020-12-15 | 13G | Lyra Therapeutics, Inc. LYRA | Ikarian Capital LLC | 785,364 6.100% | 785,364 (New Position) | Filing History |
| 2020-11-17 9:43 pm Purchase | 2020-11-17 | 13G | PROTEOSTASIS THERAPEUTICS INC PTI | Ikarian Capital LLC | 2,650,347 5.100% | 2,650,347 (New Position) | Filing History |
| 2020-09-14 5:00 pm Purchase | 2020-09-01 | 13G | TRACON Pharmaceuticals, Inc. TCON | Ikarian Capital LLC | 108,127 16.400% | 108,127 (New Position) | Filing History |
| 2020-06-18 09:11 am Purchase | 2020-06-10 | 13G | Celldex Therapeutics, Inc. CLDX | Ikarian Capital LLC | 1,592,439 7.100% | 1,592,439 (New Position) | Filing History |